Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Open Medicine

formerly Central European Journal of Medicine

Editor-in-Chief: Darzynkiewicz, Zbigniew


IMPACT FACTOR 2018: 1.221

CiteScore 2018: 1.01

SCImago Journal Rank (SJR) 2018: 0.329
Source Normalized Impact per Paper (SNIP) 2018: 0.479

ICV 2017: 152.94

Open Access
Online
ISSN
2391-5463
See all formats and pricing
More options …
Volume 9, Issue 2

Issues

Volume 10 (2015)

Serum induced CD63 and CD203c activation tests in chronic urticaria

Anzelika Chomiciene
  • Faculty of Medicine, Clinic of Infectious, Chest Diseases, Dermatovenerology and Allergology, Vilnius University, M.K. Ciurlionio 21, 03101, Vilnius, Lithuania
  • Vilnius University Hospital Santariskiu Klinikos, Santariskiu 2, 08661, Vilnius, Lithuania
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Laimute Jurgauskiene
  • Faculty of Medicine, Clinic of Cardiovascular Diseases, Vilnius University, M.K. Ciurlionio 21, 03101, Vilnius, Lithuania
  • Vilnius University Hospital Santariskiu Klinikos, Santariskiu 2, 08661, Vilnius, Lithuania
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Marek Kowalski
  • Department of Immunology, Rheumatology and Allergy, Medical University of Lodz, ul. Pomorska 251, 92-213, Lodz, Poland
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Audra Blaziene
  • Faculty of Medicine, Clinic of Infectious, Chest Diseases, Dermatovenerology and Allergology, Vilnius University, M.K. Ciurlionio 21, 03101, Vilnius, Lithuania
  • Vilnius University Hospital Santariskiu Klinikos, Santariskiu 2, 08661, Vilnius, Lithuania
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2014-02-13 | DOI: https://doi.org/10.2478/s11536-013-0274-2
  • [1] Powell R.J., Du Toit G.L., Siddique N., Leech S.C., Dixon T.A., Clark A.T., et al., BSACI guidelines for the management of chronic urticaria and angiooedema, Clin Exp Allergy, 2007, 37(5), 631–650 http://dx.doi.org/10.1111/j.1365-2222.2007.02678.xCrossrefGoogle Scholar

  • [2] Sheikh J., Autoantibodies to the high-affinity IgE receptor in chronic urticaria: how important are they, Curr Opin Allergy Clin Immunol., 2005, 5(5), 403–407 http://dx.doi.org/10.1097/01.all.0000182540.45348.bcCrossrefGoogle Scholar

  • [3] Grattan C. E., Autoimmune urticaria, Immunol Allergy Clin North Am., 2004, 24(2), 163–181 http://dx.doi.org/10.1016/j.iac.2004.01.003CrossrefGoogle Scholar

  • [4] Irinyi B., Szeles G., Gyimesi E., Tumpek J., Heredi E., Dimitrios G., et al., Clinical and laboratory examinations in the subgroups of chronic urticaria, Int Arch Allergy Immunol., 2007, 144(3), 217–225 http://dx.doi.org/10.1159/000103995CrossrefWeb of ScienceGoogle Scholar

  • [5] Sabroe R.A., Seed P.T., Francis D.M., Barr R.M., Black A.K., Greaves M.W., Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies, J Am Acad Dermatol., 1999, 40(3), 443–450 http://dx.doi.org/10.1016/S0190-9622(99)70495-0CrossrefGoogle Scholar

  • [6] Zuberbier T., Bindslev-Jensen C., Canonica W., Grattan C.E., Greaves M.W., Henz B.M. et al., EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria, Allergy, 2006, 61(3), 316–320 http://dx.doi.org/10.1111/j.1398-9995.2005.00964.xCrossrefWeb of ScienceGoogle Scholar

  • [7] Sabroe R.A., Grattan C.E., Francis D.M., Barr R.M., Kobza Black A., Greaves M.W., The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria, Br J Dermatol., 1999, 140(3), 446–452 http://dx.doi.org/10.1046/j.1365-2133.1999.02707.xCrossrefGoogle Scholar

  • [8] Fiebiger E., Maurer D., Holub H., Reininger B., Hartmann G., Woisetschlager M., et al., Serum IgG autoantibodies directed against the alpha chain of Fc epsilon RI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients, J Clin Invest., 1995, 96(6), 2606–2612 http://dx.doi.org/10.1172/JCI118325CrossrefGoogle Scholar

  • [9] Greaves M., Autoimmune urticaria, Clin Rev Allergy Immunol., 2002, 23(2), 171–183 http://dx.doi.org/10.1385/CRIAI:23:2:171CrossrefGoogle Scholar

  • [10] Asero R., Lorini M., Chong S.U., Zuberbier T., Tedeschi A., Assessment of histamine-releasing activity of sera from patients with chronic urticaria showing positive autologous skin test on human basophils and mast cells, Clin Exp Allergy, 2004, 34(7), 1111–1114 http://dx.doi.org/10.1111/j.1365-2222.2004.01997.xCrossrefGoogle Scholar

  • [11] De Swerdt A., Van Den Keybus C., Kasran A., Cadot P., Neyens K., Coorevits L., et al., Detection of basophil-activating IgG autoantibodies in chronic idiopathic urticaria by induction of CD 63, J Allergy Clin Immunol., 2005, 116(3), 662–667 http://dx.doi.org/10.1016/j.jaci.2005.04.042CrossrefGoogle Scholar

  • [12] Frezzolini A., Provini A., Teofoli P., Pomponi D., De Pita O., Serum-induced basophil CD63 expression by means of a tricolour flow cytometric method for the in vitro diagnosis of chronic urticaria, Allergy, 2006 Sep, 61(9), 1071–1077 http://dx.doi.org/10.1111/j.1398-9995.2006.01033.xCrossrefGoogle Scholar

  • [13] Gyimesi E., Sipka S., Danko K., Kiss E., Hidvegi B., Gal M., et al., Basophil CD63 expression assay on highly sensitized atopic donor leucocytes-a useful method in chronic autoimmune urticaria, Br J Dermatol, 2004 Aug; 151(2), 388–396 http://dx.doi.org/10.1111/j.1365-2133.2004.06042.xCrossrefGoogle Scholar

  • [14] Szegedi A., Irinyi B., Gal M., Hunyadi J., Danko K., Kiss E., et al. Significant correlation between the CD63 assay and the histamine release assay in chronic urticaria, Br J Dermatol, 2006, 155(1), 67–75 http://dx.doi.org/10.1111/j.1365-2133.2006.07205.xCrossrefGoogle Scholar

  • [15] Wedi B., Novacovic V., Koerner M., Kapp A., Chronic urticaria serum induces histamine release, leukotriene production, and basophil CD63 surface expression—inhibitory effects ofanti-inflammatory drugs, J Allergy Clin Immunol, 2000, 105(3), 552–560 http://dx.doi.org/10.1067/mai.2000.104939CrossrefGoogle Scholar

  • [16] Gentinetta T., Pecaric-Petkovic T., Wan D., Falcone F. H., Dahinden C. A., Pichler W. J., et al., Individual IL-3 priming is crucial for consistent in vitro activation of donor basophils in patients with chronic urticaria, J Allergy Clin Immunol, 2011, 128, 1227–1234 http://dx.doi.org/10.1016/j.jaci.2011.07.021Web of ScienceCrossrefGoogle Scholar

  • [17] Yasnowsky K.M., Dreskin S.C., Efaw B., Schoen D., Vedanthan P.K., Alam R. et al., Chronic urticaria sera increase basophil CD203c expression, J Allergy Clin Immunol, 2006, 117(6), 1430–1434 http://dx.doi.org/10.1016/j.jaci.2006.02.016CrossrefGoogle Scholar

  • [18] Tedeschi A., Asero R., Cugno M., Basophil activation test and autologous serum skin test: Not overlapping tests in chronic urticaria, J Allergy Clin Immunol, 2012, 280–281 CrossrefWeb of ScienceGoogle Scholar

  • [19] Confino-Cohen R., Chodick G., Shalev V., Leshno M., Kimhi O., Goldberg A., Chronic urticaria and autoimmunity: Association found in a large population study, J Allergy Clin Immunol, 2012, 129, 1307–1313 http://dx.doi.org/10.1016/j.jaci.2012.01.043CrossrefGoogle Scholar

  • [20] Asero R., Tedeschi A., Lorini M., Autoreactivity is highly prevalent in patients with multiple intolerances to NSAIDs, Ann Allergy Asthma Immunol, 2002, 88(5), 468–472 http://dx.doi.org/10.1016/S1081-1206(10)62384-8CrossrefGoogle Scholar

  • [21] Erbagci Z. Multiple NSAID intolerance in chronic idiopathic urticaria is correlated with delayed, pronounced and prolonged autoreactivity. J Dermatol, 2004, 31(5), 376–382 CrossrefGoogle Scholar

  • [22] Boumiza R., Monneret G., Forissier M.F., Savoye J., Gutowski M.C., Powell W.S. et al., Marked improvement of the basophil activation test by detecting CD203c instead of CD63, Clin Exp Allergy, 2003, 33(2), 259–265 http://dx.doi.org/10.1046/j.1365-2222.2003.01594.xCrossrefGoogle Scholar

  • [23] Eberlein-Konig B., Varga R., Mempel M., Darsow U., Behrendt H., Ring J., Comparison of basophil activation tests using CD63 or CD203c expression in patients with insect venom allergy, Allergy, 2006, 61(9), 1084–1085 http://dx.doi.org/10.1111/j.1398-9995.2006.01122.xCrossrefGoogle Scholar

  • [24] Sudheer P.S., Hall J.E., Read G.F., Rowbottom A.W., Williams P.E., Flow cytometric investigation of peri-anaesthetic anaphylaxis using CD63 and CD203c, Anaesthesia, 2005, 60(3), 251–256 http://dx.doi.org/10.1111/j.1365-2044.2004.04086.xCrossrefGoogle Scholar

About the article

Published Online: 2014-02-13

Published in Print: 2014-04-01


Citation Information: Open Medicine, Volume 9, Issue 2, Pages 339–347, ISSN (Online) 2391-5463, DOI: https://doi.org/10.2478/s11536-013-0274-2.

Export Citation

© 2014 Versita Warsaw. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License. BY-NC-ND 3.0

Comments (0)

Please log in or register to comment.
Log in